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The addition of a hexahistidine tag to the N terminus
of the hepatitis B capsid protein gives rise to a self-
assembled particle with 80 sites of high local density
of histidine side chains. Iron protoporphyrin IX has
been found to bind tightly at each of these sites,
making a polyvalent system of well-defined spacing
between metalloporphyrin complexes. The spectro-
scopic and redox properties of the resulting particle
are consistent with the presence of 80 site-isolated
bis(histidine)-bound heme centers, comprising a
polyvalent b-type cytochrome mimic.
INTRODUCTION
Iron porphyrins (hemes) are among the most versatile cofactors
utilized in nature (Chapman et al., 1997). Heme-containing pro-
teins perform crucial biological functions such as substrate oxi-
dation (Ortiz de Montellano, 1995), electron transfer (Gray and
Winkler, 1996), and O2 transport (Antonini and Brunori, 1971).
Thus, the design of novel heme systems that either mimic or alter
the activity of native metalloproteins is an area of intense interest
and active research (Reedy and Gibney, 2004). Site-directed
mutagenesis is commonly utilized for directmodification of a pro-
tein scaffold (Stayton et al., 1989), whereas the construction of
artificial heme protein mimics has been primarily achieved
through the synthesis of elaborate small-molecule iron porphyrin
compounds (Collman et al., 2004; Feiters et al., 2000) and by the
design of heme-binding four-helix bundles (Fahnenschmidt
et al., 2001; Reedy et al., 2003; Sakamoto et al., 1999; Shifman
et al., 1998). Consequently, numerous structures featuring dis-
crete isolated hemes are available for functional studies. The re-
cent development of scaffolds capable of binding and displaying
multiple heme groups is of particular interest (Biemans et al.,
1998; Choma et al., 1994; Reedy and Gibney, 2004; Shifman
et al., 1998; Weyermann et al., 1999; see also the Supplemental
Data available with this article online), inspired by nature’s useChemistry & Biologyof clustered porphyrin-type cofactors for energy collection and
multistep electron transfer.
Virus capsids are attractive platforms for the construction of
novel nanomaterials including hybrid structures that combine
biological macromolecules with inorganic complexes. Numer-
ous reports describe the use of viruses and virus-like particles
as platforms for the polyvalent display of materials such as fluo-
rescent dyes and small molecules (Allen et al., 2005; Gillitzer
et al., 2002; Hooker et al., 2004; Miller et al., 2007; Schlick et al.,
2005; Sen Gupta et al., 2005a; Soto et al., 2006; Wang et al.,
2002), electroactive metal complexes (Steinmetz et al., 2006),
DNA (Strable et al., 2004), quantum dots (Portney et al., 2005),
peptides (Sen Gupta et al., 2005a), carbohydrates (Kaltgrad
et al., 2007; Sen Gupta et al., 2005a, 2005b), polymers (Niu
et al., 2006; Schlick et al., 2005; Sen Gupta et al., 2005a), and
proteins (Sapsford et al., 2006; Sen Gupta et al., 2005a). Our
laboratory has recently turned to the core antigen of hepatitis
B virus (HBV) as a scaffold for chemical and genetic modification
and polyvalent display, following the work of Pumpens and
coworkers (Lachmann et al., 1999; Pumpens and Grens, 1999,
2001). We describe here the self-assembly of a polyvalent metal-
loporphyrin-decorated particle by genetic introduction of poten-
tial iron-binding ligands into the capsid structure. Virus scaffolds,
and a detailed knowledge of their chemistry, provide the capabil-
ity to control the density and spacing of light-harvesting units in
ways that may prove advantageous in mimicking natural sys-
tems. Readers should take note of an elegant report by Francis
and coworkers that is particularly relevant to this goal (Miller
et al., 2007).
RESULTS AND DISCUSSION
Virus-like particles (VLPs) of HBV are expressed in Escherichia
coli largely as T = 4 icosahedral particles of 30 nm diameter,
composed of 240 copies of the truncated coat protein (149
amino acids; designated CP149 or wild-type), and displaying
120 four-helix bundles in the form of ‘‘spikes’’ that protrude
from the surface of the thin protein shell (Figure 1A; Wynne
et al., 1999). Approximately 5% of the particles formed are15, 513–519, May 2008 ª2008 Elsevier Ltd All rights reserved 513
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Polyvalent Virus Capsid-Heme AdductsFigure 1. Capsid Structures
(A and B) Cryoelectron microscopic reconstruc-
tion of (A) wild-type HBV (resolution 9.2 A˚) and
(B) HBV(His6)240 (resolution 8.3 A˚).
(C) Difference map, showing in yellow the density
observed in HBV(His6)240 but not in wild-type
HBV, overlaid on the wild-type HBV density in
white. The yellow material therefore presumably
represents the His6 tags inserted at the N terminus
of each protein subunit, three of which come
together at the three-fold symmetry axis.
Close-up views down a three-fold axis are shown
below the whole-particle images.T = 3 assemblies of 180 capsid proteins, but these can be re-
moved by ultracentrifugation through a 5%–25% sucrose gradi-
ent. Genetic modifications of HBV have been made near the tip
of the four-helix bundles, as well as at the N and C termini of the
protein subunits (Koletzki et al., 1999;Wizemann et al., 2000).We
engineered the addition of the sequence His-His-His-His-His-
His-Gly-Ala-Ile-Glu-Gly-Asp-Cys to the N terminus, which lies
on the outer capsid surface at the edge of the large pore at the
three-fold symmetry axis. The construct was expressed in
E. coli cells, and VLPswere isolated using the protocol described
in the Experimental Procedures. Here we describe the binding of
iron(III) protoporphyrin IX to the modified particles bearing the
hexahistidine-containing sequences, designated HBV(His6)240.
Whereas the incorporation of His6 tags into proteins is a common
strategy for purification by immobilized metal-affinity chroma-
tography (Gaberc-Porekar and Menart, 2001), we believe this
is the first reported example of the use of hexahistidine peptide
sequences to anchor transition metal complexes for polyvalent
display.
HBV(His6)240 particles were analyzed by cryoelectron micros-
copy and compared to the particle composed of the wild-type
CP149 sequence (Figure 1). The two structures were essentially
identical with the exception of additional density occupying
a portion of the pore at the three-fold symmetry axis at the
base of the protruding four-helix bundles and corresponding to
the location of the N terminus. This additional N-terminal density
is shown in yellow in Figure 1C, and is similar to a previously
reported case of an HBV chimera with an N-terminal peptide
extension (Conway et al., 1998). The HBV(His6)240 particles were
not retained on an immobilized cobalt column commonly used
to bind His-tagged proteins, or on an anion-exchange column
(Supplemental Data), in spite of the addition of 1440 histidine
residues per particle, indicating that the added sequences were
not accessible to the column stationary phase. Presumably, the
radial four-helix bundles are not sufficiently flexible to allow a
metal-containing surface to interact with His6 sequences on
the ‘‘floor’’ of the capsid structure.
HBV(His6)240 was incubated with one equivalent of iron(III) pro-
toporphyrin IX (Fe[PPIX], or ‘‘heme’’) per protein subunit in 0.1 M
potassium phosphate buffer at pH 7. Purification of the resulting
capsids was accomplished by two consecutive sets of sucrose514 Chemistry & Biology 15, 513–519, May 2008 ª2008 Elsevier Ltdgradients and ultracentrifugation, resulting in recovery of ap-
proximately 40% of the original virions; this yield is somewhat
lower than the normal 60%–70% usually obtained with this pro-
tocol. Nonspecific adsorption of polyaromatic molecules to virus
capsids is common in our experience and two gradients were
required for the removal of weakly associated heme, visible as
a broad and diffuse band that accompanied the narrow protein
band of the purified material. Heme did not associate with HBV
particles lacking His6 tags, or with the individual dimers of dis-
assembled HBV(His6)240 particles, as determined by UV-vis
spectroscopy and size-exclusion chromatography (SEC).
Figure 2A shows the SEC analysis of purified heme-
HBV(His6)240, confirming their intact nature by coelution of the vi-
ral protein (detected at 280 nm) and the heme group (detected at
412 nm) at the volume characteristic of intact particles. Uncom-
plexed HBV(His6)240 elutes at the same volume, indicating
that the modified particles are intact and do not aggregate. The
iron(III) centers apparently do not interact significantly with the
column resin, consistent with the presence of coordinatively sat-
urated and/or inaccessible metal ions. Heme-HBV(His6)240 was
quite stable upon extended storage (several weeks at 4C), nota-
ble because the covalent attachment of polyaromatic dye
molecules was found in separate work to cause capsid decom-
position, presumably by disruption of noncovalent interactions
between subunits.
A loading of 80 ± 8 heme units per particle was established by
a combination of quantitative protein assay and inductively cou-
pled plasma optical emission spectrometry (ICP-OES) for iron,
for multiple preparations of heme-HBV(His6)240. This value repre-
sents the binding of one heme for every three protein subunits,
suggesting that the close positioning of the His6 tags at each
three-fold symmetry axis provides a single heme binding pocket.
It seems likely that one heme is bound at this location by 2 of the
18 histidine amino acids provided by three adjacent His6 tags,
and there is either no room or insufficient conformational free-
dom to provide histidine ligands for a second Fe-porphyrin
moiety. Cryo-EM analysis of heme-HBV(His6)240 showed no sig-
nificant difference in structure compared to the particle before
treatment with heme (data not shown), suggesting that either
the bound heme is found in a range of structurally distinct confor-
mations among the 80 binding sites and so is not visualized uponAll rights reserved
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Polyvalent Virus Capsid-Heme AdductsFigure 2. Characterization of Heme-Derivatized HBV Particles
(A) Size-exclusion FPLC of (heme)80HBV(His6)240 showing 280 nm (black) and 412 nm (blue) absorption traces. The trace of HBV(His6)240 (red) is shown for
comparison.
(B) UV-vis spectra of oxidized (black) and reduced (red) (heme)80HBV(His6)240 (0.3 mg/ml VLP, 5.6 mM iron) in 0.1 M potassium phosphate buffer (pH 7). The in-
tense absorption below 390 nm of the reduced sample is due to sodium dithionite. The spectrum of free iron(III) protoporphyrin IX (blue) is shown for comparison
(20 mM, 2% DMSO).
(C) UV-vis spectra of (heme)80HBV(His6)240 (0.3 mg/ml VLP, 5.6 mM iron) in the absence (black) and presence (red) of 1 M cyanide in 0.1 M potassium phosphate
buffer (pH 7).icosahedral signal averaging (likely given the large number of his-
tidine residues present at each three-fold site) or that the bound
heme-protein conformation is not sufficiently different to be re-
solved at the approximately 9 A˚ resolution of the reconstruction.
The attachment of Fe(PPIX) to HBV(His6)240 was further con-
firmed using UV-vis spectroscopy (Figure 2B). In the absence
of capsid, Fe(PPIX)Cl in 9:1 buffer:DMSOexhibited a broad Soret
band centered at 375 nm. In contrast, (heme)80HBV(His6)240 is
characterized by a narrow Soret band at 412 nm (3 z156,000
M1 cm1) and Q bands at 533 nm (3z18,000 M1 cm1) and
564 nm (3 z14,000 M1 cm1). Reduction of Fe(III) to Fe(II)
by the addition of a small amount of solid sodium dithionite
was evidenced by a shift of the Soret band to 420 nm
(3 z120,000 M1 cm1) and the appearance of two distinct
and sharp Q bands at 526 and 555 nm (3 z15,000 and
20,000 M1 cm1, respectively). These changes were reversible,
as removal of the reductant by either dialysis or sucrose gradients
regenerated the Fe(III) form. The spectroscopic features exhibited
by (heme)80HBV(His6)240 are indicative of low-spin iron(III) por-
phyrin ligated by two axial imidazole (histidine) groups, as
observed for b-type cytochromes (Adar, 1978).
Resonance Raman spectroscopy is highly sensitive to heme
axial ligation and supported the assignment of low-spin bis
(histidine) axial coordination for (heme)80HBV(His6)240. The high-
frequency Soret-excitation resonance Raman spectra of the
polyvalent heme particle in 0.1 M potassium phosphate buffer
at pH 7 are shown in Figure 3A. The ferric formwas characterized
by strong bands at 1640, 1580, 1507, and 1375 cm1, which
shift to 1626, 1592, 1496, and 1360 cm1 in the ferrous form.
These features closely match those of other low-spin bis(histi-
dine)-ligated hemes, and are consistent with minimal structural
rearrangement accompanying the reduction to iron(II) (Kalsbeck
et al., 1996; Shifman et al., 1998). Importantly, because there is
no evident broadening or splitting of the resonance Raman
bands, all the capsid-bound hemes can be described as having
essentially the same coordination environment (Kalsbeck et al.,
1996; Shifman et al., 1998).
The redox potentials of bis(histidine)-ligated heme proteins
range from –412 to +360 mV versus the normal hydrogenChemistry & Biologyelectrode (NHE), indicating the significant influence that polypep-
tides can have on the heme redox potential (Reedy and Gibney,
2004; Tezcan et al., 1998). Cyclic voltammetry (CV) of a degassed
solution of (heme)80HBV(His6)240 in 0.1 M potassium phosphate
buffer at pH 7 (Figure 3B) revealed a well-defined redox couple
with E1/2 = –335 mV versus Ag/AgCl (138 mV versus NHE),
consistent with the Fe(II)/Fe(III) redox process of HBV-bound,
bis(histidine)-ligated heme and comparable to that of hemes co-
ordinated by four-helix bundles (Reedy and Gibney, 2004). For
comparison, free heme in solution displayed quasi-reversible re-
dox behavior with a well-defined cathodic peak (Ep,c =383mV)
and a broad anodic wave (see the Supplemental Data), whereas
the redox potential of free (Fe[protoporphyrin IX][imidazole]2)
+
under the same conditions was found to be –420 mV versus
Ag/AgCl (–223 V versus NHE), comparable to the previously
reported value (Shifman et al., 1998). These observations further
support the assignment of the observed redox process in
Figure 3B as being due to the HBV(His6)240-bound heme.
The peak current measured for (heme)80HBV(His6)240 was di-
rectly proportional to scan rate over a large range (50–750 mV/s),
indicating a surface-confined species. Integration of the peaks
in Figure 3B yielded a cathodic:anodic charge ratio (Qp,c:Qp,a)
of 0.93, consistent with chemical reversibility. The amount of
adsorbed electroactive heme was estimated, based on the
cathodic charge passed, to be approximately 83 hemes/particle
(assuming monolayer coverage), in good agreement with the
measured loadings. Although the data are consistent with a
monolayer of HBV(His6)240 on the electrode surface, the associ-
ated heme groups display voltammetric responses atypical of
simple surface-confined electrochemistry (Bard and Faulkner,
2001). As suggested in other cases (Clark and Bowden, 1997;
Zhang et al., 1997), such deviations likely arise from different
redox-active microenvironments produced by adsorption of
the polyvalently decorated virus-like particle to the electrode
surface. A range of formal potentials and electron transfer rates
can be expected to contribute to the observed nonidealities, for
example, differential interactions with the electrode surface and
varying heme-electrode distances (Tanimura et al., 2002; Tezcan
et al., 1998).15, 513–519, May 2008 ª2008 Elsevier Ltd All rights reserved 515
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Coordination of Heme Units
(A) High-frequency Soret-excitation spectra of
(heme)80HBV(His6)240 in the ferric (lex = 406.7 nm,
bottom) and ferrous states (lex = 413.1 nm, top)
in 0.1 M potassium phosphate buffer (pH 7).
(B) Cyclic voltammogram of (heme)80HBV(His6)240
(10 mg/ml, 185 mM iron) in 0.1 M potassium
phosphate buffer (pH 7), recorded at 250 mV/s
with a glassy carbon working electrode.The strong nature of the interactions of HBV(His6)240 with
Fe(PPIX) was indicated by the addition of competing ligands.
No spectral changes were observed when (heme)80HBV(His6)240
was treated with the moderate-field azide ligand (Huang and
Kassner, 1979; Rousseau et al., 1989) in up to 1 M concentration
(105 equivalents azide with respect to Fe). The system was
also somewhat resistant to the stronger cyanide ligand. From
0.5–10 mM added KCN (100–2000 equivalents per Fe), a
modest shift of the Soret band from 412 to 415 nmwas observed
with isosbestic behavior (Supplemental Data). The identity of
the species thus formed is not clear. The displacement of
either or both coordinated histidine imidazoles would give
(Fe[heme][CN])80HBV(His6)240 or (Fe[heme][CN]2)
–. The latter
species and an analog of the former are both known to show
greater shifts in the Soret band (420–425 nm) (de Lauzon et al.,
2002; DeVito and Asher, 1989). On the other hand, the addition
of as little as 1 mM KCN (100 equivalents with respect to Fe)
suppressed the electrochemical response of Figure 3B
within the accessible potential window, suggesting some kind
of binding to the electroactive iron center. Upon the addition of
100 mM cyanide (104 equivalents per Fe), a more pronounced
(nonisosbestic) spectroscopic change occurred in the electronic
spectrum, with a Soret band at 422 nm (3z121,000 M1 cm1)
and a single Q band absorption at 545 nm (3z18,000M1 cm1)
(Figure 2C), but again no visible electrochemical signal. Control
experiments performed in the absence of HBV(His6)240 showed
that free Fe(PPIX) was easily detected by cyclic voltammetry
under the same conditions both in the presence and absence
of KCN, and also in the presence of a large excess of BSA.
Furthermore, when we tried to isolate a cyanide-coordinated
heme-HBV(His6)240 complex away from excess cyanide by
dialysis or sucrose-gradient ultracentrifugation, the putative
bound cyanide was lost and the starting (heme)80HBV(His6)240
complex was regenerated. These results suggest that
the heme unit is not extracted from the HBV particle by
cyanide ion.
SIGNIFICANCE
We show here the selective incorporation of 80 heme moie-
ties onto the surface of HBV via bis(imidazole) coordination
of capsid N-terminal His6 tags, providing a facile route to
polyvalent electroactive particles. The binding site is formed
by the symmetry of the HBV scaffold, which gives rise to
a clustering of three His6 sequences in a compact space at
80 positions around the 30 nm diameter object. This type516 Chemistry & Biology 15, 513–519, May 2008 ª2008 Elsevier Ltdof highly leveraged self-assembly is provided by virus capsid
particles more easily than by any other class of proteins,
laying the foundation for further construction of nanomate-
rials with catalytic, electron-transfer, or light-harvesting
capabilities.
EXPERIMENTAL PROCEDURES
CP149 HBV Plasmid Construction
A pET-11c plasmid containing the sequence for the first 149 amino acids of the
coat protein, designated CP149, was a generous gift fromAdamZlotnick of the
Oklahoma University Health Sciences Center. In order to place the capsid pro-
tein under inducible control, the cp149 gene was amplified from the pET-11c
plasmid using the following primers, with residues in bold constituting restric-
tion sites used for cloning: cp149f: 50-AAG AAG GAG GAT ATA GGT CTC AC
ATG GAC ATT GAC CCT-30 and cp149r: 50-TCG GGC TTT GTT AGC AGC
CGGAAGCTTATACTA AACAACCGT-30. The PCR product was sequentially
digested with HindIII and BsaI, and then ligated into a pQE-60 plasmid which
had been sequentially digested with HindIII and NcoI. (BsaI cleaves one to five
bases downstream from its recognition site. The DNA sequences were
designed with this in mind, to give compatible ends with NcoI ligation without
introducing unwanted sequence into the plasmid.) The resulting plasmid was
transformed into competent M15MA cells (a generous gift from David Tirrell
at Caltech) harboring the pREP4 plasmid yielding the expression cells
M15MA(pQE-60/CP149).
HBV(His6)240 Construction in Vector pQE-60
The His6-tagged construct consisted of hexahistidine peptide, two spacer
amino acids, the Factor Xa cleavage sequence, and a cysteine residue placed
before the CP149 sequence. The incorporation of the Factor Xa cleavage site
was designed to allow removal of the histidine tag if necessary but was not
used. The requisitegenewasconstructedbyamplifyingcp149using the follow-
ing primers, with residues in bold constituting restriction sites used for cloning:
his-hbvf: 50-AAG AAGGAGGAT ATAGGTCTCACC ATGCACCAT CACCAT
CAC CAT GCA GGA ATC GAG GG AGAC TGT GAC ATT GAC CCT TAT AAA
GAA-30 and his-hbvr: 50-TGC GGC TTT GTT AGC AGC CGG AAG CTT ATC
CTAAACAACCGT-30. ThePCRproduct was sequentially digestedwithHindIII
and BsaI and ligated into pQE-60 that was previously digested with HindIII and
NcoI. The resulting plasmid was transformed into M15MA competent cells
yielding the expression cells M15MA(pQE-60/His tag HBV).
HBV(His6)240 Construction in Vector pET-28b
During the course of the study, we experienced some difficulty with expression
from the pQE-60 plasmid due to an acquired deletion mutation in the promoter
region. While this problem was being diagnosed, expression was transferred
to the pET-28b vector, as described below. The resulting particles were iden-
tical to those obtained from pQE-60 in M15MA cells, but only a small subset of
the work described here was performed with the pET-28b system.
The gene encoding the truncatedHBV(His6)240 coat protein was amplified by
PCR to incorporate NcoI and HindIII restriction sites at the N-terminal methio-
nine and immediately after the stop codon, respectively. The PCR product and
the T7 expression vector pET-28b were separately digested with NcoI andAll rights reserved
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Cloning was performed using Top10 cells, and the final vector sequence was
confirmed by standard DNA sequencing. The pET-28b plasmid containing the
HBV(His6)240 coat protein gene was transformed into E. coli BL21 (DE3 pLysS)
cells. Details are below; note that the bacteria were grown in SOB media con-
taining the antibiotics kanamycin and chloramphenicol (50 and 34 mg/ml, re-
spectively), the cells were induced with 1 mM isopropyl-b-D thiogalactosidase
(IPTG) and harvested after 3 hr, and lysozyme was omitted from the cell lysis
buffer.
Expression and Isolation of CP149 HBV and HBV(His6)240
A single colony of cells expressing either CP149 HBV or HBV(His6)240 was
grown overnight in 5 ml of SOB media containing carbenicillin (100 mg/ml)
and kanamycin (50 mg/ml). The entire 5 ml starter culture was transferred into
500 ml of fresh SOB media supplemented with carbenicillin (100 mg/ml) and
kanamycin (50 mg/ml) and allowed to grow until an OD600 of 1.0 was reached.
IPTGwas added to a final concentration of 1mM. Induction at 37Cwas carried
out overnight for approximately 16hr.Cellswere harvested and couldbe stored
at –80C for months.
A total of 30–60 g of cells was allowed to thaw at room temperature and the
cells were resuspended in 50 ml of distilled water. Following resuspension,
200 ml of cold lysis buffer (50 mM HEPES [pH 8.0], 500 mM NaCl, 0.1 mg/ml
DNase 1, and 0.1mg/ml RNase A) was added. The cells were lysed using three
cycles of sonication for 2 min, separated by a 2 min rest between cycles. One
milligram of lysozyme was then added per ml of lysis buffer and the solution
was stirred at 4C for 1–2 hr. Insoluble cell debris was removed by centrifuga-
tion at 10,000 rpm for 30min. Ammonium sulfate was added to the supernatant
to a final concentration of 40% of saturation and allowed to stir at room
temperature for 30 min. The precipitated HBV coat protein was separated
by centrifuging the sample at 10,000 rpm for 30min, followed by resuspension
of the precipitated protein in 50 ml of buffer. Any insoluble material was
removed by centrifugation at 10,000 rpm for 15 min. NaCl was added to a final
concentration of 0.5 M and the HBV coat protein was allowed to assemble
overnight. Assembled virus-like particles were separated from smaller proteins
by ultrapelleting at 42,000 rpm for 6 hr at 4C. The pelleted capsid was resus-
pended in 3–10 ml of buffer and further purification was accomplished by
ultracentrifugation through a 10%–40%sucrose gradient for 6 hr at 4C. Finally,
the VLPs were concentrated by repeating the ultrapelleting step. Separation of
the T = 3 and T = 4 particles was accomplished by running no more than 10 mg
of capsid on a 5%–30% sucrose gradient at 28,000 rpm for 5 hr.
Characterization of HBV Particles
The purity of the isolated HBV particles was assessed using a variety of bio-
chemical techniques. An A260:A280 ratio of 0.6–0.7 was typically observed,
consistent with the fact that the particles do not encapsidate nucleic acid.
The presence and relative amounts of individual, aggregated, and disas-
sembled particles were determined by FPLC, and the purity of the protein par-
ticles was established as >95% by SDS-PAGE. Samples were also routinely
examined by negative-stain transmission electron microscopy by applying
particles at a concentration of 0.2 mg/ml to a carbon-coated formvar
transmission electron grid. The grids were stained with 2% uranyl acetate,
and visualized by a Phillips CM120 transmission electron microscope. These
observations always correlated well with FPLC characterization, in that no
evidence of broken particles was observed for routine samples by either
technique. Concentrations of unmodified HBV(His6)240 were measured by
absorbance at 280 nm; capsids at 1 mg/ml yield an absorbance of 1.74. An
overlapping absorption at 280 nm by iron(III) protoporphyrin IX necessitated
the use of a Coomassie Plus protein assay (Pierce) for the determination of
(heme)80HBV(His6)240 concentrations. A standard curve for the protein assay
was constructed using concentrations of 0.1–1 mg/ml of HBV(His6)240.
Anion-Exchange FPLC
The inability of HBV(His6)240 particles to bind to a cobalt column suggested
that their effective surface charge might also be changed by the addition of
1440 histidine residues to a smaller degree than anticipated. To explore this
question, anion-exchange FPLC was performed, and identical elution profiles
were observed for the CP149 and HBV(His6)240 particles (Supplemental Data).
We have previously shown that surface charge changes in cowpea mosaicChemistry & Biologvirus and bacteriophage Qb of much smaller magnitude are detectable by
changes in retention time using this method, and so we conclude that the
effective charge of the surface that interacts with the column is unchanged
by the addition of the N-terminal histidine tag sequence. Therefore, the surface
interactions must be dominated by the four-helix bundles.
Preparation of Samples for Cryoelectron Microscopy
Samples for cryo-EM were cleansed of the 5% of T = 3 virus-like particles by
sucrose-gradient ultracentrifugation as described above. Excess sucrose was
removed and the samples were concentrated by ultrapelleting. The pellets
were resuspended in buffer to give final concentrations of at least 10 mg/ml.
Cryoelectron Microscopy and Analysis
Samples were prepared for cryo-EM analysis by preservation in vitreous ice via
placing 4 ml of sample (10 mg/ml) and rapid-freeze plunging onto plasma-
cleaned Cflat carbon film grids using a Vitrobot (FEI). Data collection was per-
formed by Tecnai F20 electron microscopes (FEI) operating at 120 keV using
a dose of 20e/A˚2 and a nominal underfocus of 1–4 mm utilizing Leginon
data collection software (Suloway et al., 2005). For the reconstructions, 738
micrographs of wild-type HBV and 534 micrographs of HBV(His6)240 were col-
lected at a nominal magnification of 80,0003 at a pixel size of 0.14 nm at the
specimen. All micrographs were collected on a 4 k3 4 k CCD camera (Gatan).
The contrast transfer function (CTF) for each micrograph was estimated
using the automated CTF estimation (ACE) package (Mallick et al., 2005).
Wild-type HBV particles (8,906) and HBV(His6)240 (23,187) particles were
extracted from the collected data at a box size of 304 3 304 pixels. The HBV
particles were binned by a factor of two for the reconstruction. Phase correc-
tion of the single particles and subsequent three-dimensional refinement was
carried out with the EMAN software package (Ludtke et al., 1999). The ampli-
tudes of the resulting refined structures were adjusted with the SPIDER soft-
ware package (Frank et al., 1996). Resolution of the final densities was deter-
mined to be 9.2 and 8.3 A˚, respectively, according to 0.5 Fourier shell
correlation criteria. Rigid-body docking of crystal structures into the recon-
struction density (not shown) and graphical representations were produced
by the Chimera visualization software package (Goddard et al., 2005, 2007).
Preparation of (Heme)80HBV(His6)240
To HBV(His6)240 (40 mg) in buffer (14 ml) was added a DMSO solution of Fe(III)
protoporphyrin IX (1 mM, 2.2 ml). The volume of DMSO was increased (1.8 ml)
such that the total organic solvent comprised 20% (v/v) of the total solution.
The resulting dark red solution was incubated at room temperature for 1 hr.
The reaction mixture was then distributed equally among six 40 ml 10%–
40% sucrose gradients and purified by ultracentrifugation at 28,000 rpm for
6 hr. A broad diffuse brown band of lower density than the tight red protein
band was discarded. Protein bands were combined and ultrapelleted at
42,000 rpm for 6 hr, and the resulting red pellets were resuspended in buffer
(2ml/pellet). Undissolvedmaterial was removed by low-speed centrifugation
at 9,500 rpm for 15 min. A second set of sucrose gradients, followed by ultra-
pelleting, afforded pure (heme)80HBV(His6)240 (15 mg, 38%). Cryo-EM analysis
of (heme)80HBV(His6)240 was unable to resolve any differences in structure
compared to the HBV(His6)240 starting material.
Resonance Raman Spectroscopy
Resonance Raman spectra were acquired with a Spex 1877 triple spectro-
graph equipped with a holographically etched 2400 groove/mm grating in
the final stage. A camera lens (Canon 50 mm f/1.4) was used to collect the
scattered light at 90 to the incident laser beam. The excitation wavelengths
of 406.7 and 413.1 nm were provided by the outputs of a Coherent Innova
200-K3 Kr ion laser. An 1152 3 298 pixel, front-illuminated, UV-enhanced,
charge-coupled device (CCD) was employed as the detector (Princeton Instru-
ments; LN/CCD equipped with an EEV 1152-UV chip). The laser powers were
typically 5 mW, and the frequencies were calibrated using the known frequen-
cies of indene and CCl4. The accuracy of strong and/or isolated bands is ±
1 cm1. The slit widths were set to provide 2 cm1 resolution.
Electrochemistry
Cyclic voltammograms were recorded using a CH Instruments Electrochemi-
cal Workstation. A glassy carbon working electrode (0.07 cm2), an Ag/AgCly 15, 513–519, May 2008 ª2008 Elsevier Ltd All rights reserved 517
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Polyvalent Virus Capsid-Heme Adductsreference electrode, and a platinum wire auxiliary electrode were used. The
working electrode was polished with a 0.3 mm alumina slurry, followed by brief
sonication. Electrochemical measurements were conducted at ambient tem-
perature under argon in a two-compartment cell separating the reference
electrode from the working and counter electrodes with a modified Luggin
capillary. Samples of (heme)80HBV(His6)240 were first degassed by 20 vac-
uum/argon backfill cycles, then gently purged with argon immediately prior
to voltammetry. All other solutions were thoroughly degassed with argon.
Estimation of the electrode monolayer coverage was performed as follows.
Integration of the area under the peak of Figure 3B yields a value of approxi-
mately 100 nC or1 pmol heme. A particle of 35 nm diameter has a cross-sec-
tional area of 9.6 3 1012 cm2/molecule. On an electrode with area 0.07 cm2,
the theoretical monolayer coverage corresponds to 0.012 pmol of HBV.
SUPPLEMENTAL DATA
Supplemental Data include three figures and Supplemental Experimental Pro-
cedures and can be found with this article online at http://www.chembiol.com/
cgi/content/full/15/5/513/DC1/.
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